16% of maternal deaths, and a blood pressure cuff that is not always there
What happened
On 7 October 2026 the World Health Organization and its partners launched a global roadmap for hypertensive disorders of pregnancy, covering 2026 to 2035 and beyond. Hypertensive disorders of pregnancy means high blood pressure that develops during pregnancy. The best known form is pre-eclampsia, which can also affect the kidneys, liver, blood and brain, and which can become life-threatening quickly. WHO's Director-General set out the scale at a media briefing the same day. Hypertensive disorders account for about 16% of maternal deaths worldwide. That is around 42,000 deaths a year. They also contribute to more than 500,000 stillbirths and newborn deaths. The roadmap follows a Global Pre-eclampsia Summit that WHO and the HRP research programme hosted in Kigali, Rwanda, from 5 to 8 May 2026. It sets out coordinated action across five areas: research and innovation; norms and standards; access to health products; implementation; and advocacy and accountability. It is designed to contribute to the United Nations Sustainable Development Goal targets 3.1 and 3.2, which cover maternal deaths and the deaths of newborns and young children.
Why this matters
Pre-eclampsia is one of those conditions where the medicine is not really the hard part. The tools to spot it are simple: a blood pressure cuff and a urine test. The treatments that save lives, including magnesium sulfate for seizures, are decades old and cheap. The problem is that those simple things are not reliably available everywhere. WHO points to countries where there is no dependable access to basic blood pressure measurement, testing or essential medicines. It also points to weak referral systems, too few trained health workers and limited emergency obstetric services, all of which delay care at the moment when hours matter. There is a second gap, and WHO calls it an innovation gap. The scale of the problem is enormous, yet very few medicines exist to prevent or treat pre-eclampsia itself. Most care is about managing it and deciding when to deliver the baby. Research funding has not matched the death toll. For readers in the UK, this is mostly a story about other countries. But not entirely. The reason UK antenatal care checks your blood pressure at every appointment is precisely because this condition is common, it can develop silently, and catching it early changes the outcome. The roadmap is a reminder of what those routine checks are for.
What the evidence actually says
The figures WHO gave are specific, and worth repeating carefully. About 16% of maternal deaths globally are linked to hypertensive disorders of pregnancy. That equates to roughly 42,000 deaths. More than 500,000 stillbirths and newborn deaths are also attributed to these disorders. The roadmap itself is not a clinical guideline. It does not tell a midwife what to do at the bedside. It is a ten-year plan for how governments, researchers, funders and manufacturers should coordinate, so that proven treatments and future innovations actually reach the women and babies who need them. Its five areas are deliberately broad. Research and innovation addresses the shortage of new preventive and therapeutic options. Norms and standards covers the guidance clinicians follow. Access to health products deals with the supply of medicines and diagnostics. Implementation is about making services work in real health systems. Advocacy and accountability is about keeping the issue funded and measured. WHO frames the whole thing around equitable access to quality care, with particular attention to low- and middle-income countries, where most of these deaths happen. What the roadmap does not claim is a breakthrough. There is no new drug here and no new test. It is an attempt to organise effort around a problem that has been well understood for a long time and under-addressed anyway.
Practical advice
If you are pregnant, or supporting someone who is, the practical lessons are about not skipping the basics. Go to your antenatal appointments, including the ones that feel routine. The blood pressure and urine checks are the main way pre-eclampsia is caught before it becomes dangerous, and it often causes no symptoms at first. Know the warning signs and do not wait. A bad headache that will not shift, changes to your vision such as flashing lights or blurring, pain just below the ribs, sudden swelling of the face, hands or feet, and feeling or being sick in later pregnancy all warrant urgent contact with your midwife or maternity unit. Trust your instincts rather than waiting for the next appointment. Tell your midwife about your history. Previous pre-eclampsia, high blood pressure before pregnancy, diabetes, kidney disease, autoimmune conditions, a first pregnancy, a multiple pregnancy and a family history all affect your risk, and your care can be adjusted. If you take blood pressure medicines, do not change or stop them on your own. Some are suitable in pregnancy and some are not, and that is a conversation to have with your GP, midwife or pharmacist before anything changes. If you have been given a home blood pressure monitor, use it as instructed and write the readings down. A record is far more useful than a memory.
What to know
WHO and partners launched a global roadmap for hypertensive disorders of pregnancy on 7 October 2026, covering 2026 to 2035 and beyond. These disorders, including pre-eclampsia, account for about 16% of maternal deaths worldwide - roughly 42,000 deaths a year - and contribute to more than 500,000 stillbirths and newborn deaths. WHO points to missing basics in many countries, including blood pressure measurement, testing and essential medicines, alongside weak referral systems and too few trained staff. It also highlights an innovation gap: very few medicines exist to prevent or treat pre-eclampsia. The roadmap coordinates action across research and innovation, norms and standards, access to health products, implementation, and advocacy and accountability. It followed a Global Pre-eclampsia Summit in Kigali, Rwanda, held 5 to 8 May 2026. Sources: World Health Organization, "Global roadmap for hypertensive disorders of pregnancy from 2026 to 2035 and beyond", 7 October 2026, https://www.who.int/publications/i/item/9789240125483 ; World Health Organization, "WHO Director-General's opening remarks at the media briefing - 7 October 2026", 7 October 2026, https://www.who.int/news-room/speeches/item/who-director-general-s-opening-remarks-at-the-media-briefing---7-october-2026 ; World Health Organization, "Global pre-eclampsia summit", 5 to 8 May 2026, https://www.who.int/news-room/events/detail/2026/05/05/default-calendar/global-pre-eclampsia-summit This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional.
Related articles
Six hours, not never: the ICU filter notice the MHRA issued today
The UK's medicines and devices regulator has issued a new safety notice to hospitals, and it is about timing. On 13 October 2026 the Medicines and Healthcare p…
Eight pages to a minister: what the data guardian says trust is worth
On 12 October 2026, the government published a letter about who should be trusted with NHS patient data. It was written by Dr Nicola Byrne, the National Data G…
Update: the tests came back, and it was not plague
This is a follow-up to a story we covered on 5 October, when nearly 200 people were being monitored after the death of a laboratory worker in Siberia. There has…